Werewolf Therapeutics Inc

NASDAQ HOWL

Data sourced from iex and EODHD
Download Data

Werewolf Therapeutics Inc Income Statement 2020 - 2024

This table shows the Income Statement for Werewolf Therapeutics Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 1 2 6 8 4 7 5 4 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 0 0 0 1 1 1 - - - - - - - - - - -
Gross Profit
M 0 1 5 7 4 7 5 4 - - - - - - - - -
Operating Expenses
M 17 14 15 13 16 20 18 19 - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 5 5 4 5 5 5 4 5 4 4 4 4 3 2 1 1 1
Research and Development (R&D) Expenses
M 13 10 11 10 12 16 13 14 11 13 10 7 5 5 5 4 3
Other Operating Expenses
M 0 0 0 -1 -1 -1 0 0 - - - - - - - - -
Costs and Expenses
M 17 14 15 13 16 20 - - - - - - - - - - -
Operating Income
M -17 -13 -9 -6 -12 -13 -13 -15 -15 -18 -14 -11 -7 -7 -6 -5 -4
Interest Expense
M 1 1 1 - -1 1 1 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 7 0
EBT
M -16 -12 -8 -5 -12 -12 -12 -15 -15 -18 -14 -11 -7 -7 -6 2 -4
Income Tax Provision
M 0 2 0 -1 -1 -1 -1 0 0 0 - 0 0 0 - 0 -
Income after Tax
M -16 -14 -8 -4 -11 -11 -11 -14 -15 -18 - -11 -7 -7 - 2 -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 -304 0 57 95 - 0 0 0
Net Income
M - - - -5 -12 -12 -12 -15 -15 286 -14 -68 -102 - -6 2 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 41,607,279.00 36,570,280.00 35,654,000.00 35,558,000.00 34,785,000.00 30,735,000.00 29,764,000.00 27,517,000.00 27,393,000.00 27,270,000.00 27,188,000.00 17,750,000.00 26,289,359.00 8,970,732.00 8,970,732.00 8,970,732.00 8,970,732.00
EBITDA
M -17 -13 -9 -6 -12 -13 -12 -15 -15 -18 -14 -11 -7 -7 -6 -5 -4
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -17 -13 -10 -6 -13 -14 -13 -15 -15 -18 -14 -11 -7 -7 -6 -5 -4
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.00 -17.54 5.37 19.50 5.56 10.47 4.99 2.59 0.15 0.27 - 0.47 0.44 0.38 - -1.06 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% 37.47 69.35 92.45 90.43 82.95 92.34 100.00 100.00 - - - - - - - - -
Operating Income Margin
% -2,312.94 -863.56 -156.88 -75.08 -273.81 -180.96 -252.29 -360.95 - - - - - - - - -
Net Income Margin
% - - - -63.09 -268.41 -163.81 -240.30 -351.83 - - - - - - - - -
EBITDA Ratio
% -2,250.40 -832.91 -156.88 -69.71 -273.81 -180.96 -244.16 -356.49 - - - - - - - - -
EBIT Ratio
% -2,312.94 -863.56 -164.42 -75.08 -283.33 -186.68 -252.29 -360.95 - - - - - - - - -
EBT Ratio
% -2,182.35 -799.67 -140.50 -63.09 -268.41 -163.81 -240.30 -351.83 - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email